|
0
|
32
|
8olqA |
Di3 abeta fibril from tg-swdi mouse |
|
0
|
31
|
8ol5A |
Murine type ii abeta fibril from arte10 mouse |
|
0
|
31
|
8ol2A |
Murine type ii abeta fibril from app23 mouse |
|
0
|
31
|
8ol6A |
Murine type ii abeta fibril from tgappswe mouse |
|
0
|
32
|
8ol7A |
Murinearc type i abeta fibril from tg-apparcswe mouse |
|
23
|
137
|
8pfbA |
Structure of a heteropolymeric type 4 pilus from a monoderm bacterium |
|
5
|
36
|
7zzvA |
Prostatic acid phosphatase (pap) fragment (85-120) |
|
4
|
40
|
7zroA |
The spatial structure of amyloidogenic sem1(68-107) peptide |
|
0
|
18
|
7zrfA |
Spatials structure of amyloidogenic sem1(68-85) peptide |
|
0
|
135
|
7x83A |
Cryo-em structure of the tmem106b fibril from normal elder |
|
1
|
135
|
7x84A |
Cryo-em structure of the tmem106b fibril from parkinson's disease dementia |
|
0
|
151
|
7vzfA |
Cryo-em structure of amyloid fibril formed by full-length human sod1 |
|
20
|
180
|
7uegA |
Cryo-em of bundling pili from pyrobaculum calidifontis |
|
7
|
21
|
7t0xA |
Structure of the larger diameter psmalpha3 nanotube |
|
12
|
44
|
7t8uA |
Structure of psmbeta2 nanotubes |
|
6
|
21
|
7szzA |
Structure of the smaller diameter psmalpha3 nanotubes |
|
0
|
17
|
7qv5A |
Amyloid fibril from the antimicrobial peptide uperin 3.5 |
|
32
|
92
|
7o92A |
Hypothetical protein uy81_c0065g0003 residues 18-54 from candidatus giovannonibacteria bacterium fused to gcn4 adaptors |
|
30
|
81
|
7o9vA |
Hypothetical protein omm_04225 residues 244-274 from candidatus magnetoglobus multicellularis fused to gcn4 adaptors |
|
34
|
82
|
7oaaA |
Conserved hypothetical protein residues 311-335 from candidatus magnetomorum sp. hk-1 fused to gcn4 adaptors |
|
36
|
73
|
7o97A |
Hypothetical protein uy81_c0065g0003 from candidatus giovannonibacteria bacterium converted into a canonical coiled coil |
|
0
|
37
|
7f29A |
Cryo-em structure of the fibril formed by disaccharide-modified amyloid-beta(1-42) |
|
0
|
83
|
7ozgA |
Pmca-amplified alpha-synuclein fibril polymorph, parkinson's disease patient-derived seeds |
|
0
|
58
|
7ozhA |
Pmca-amplified alpha-synuclein fibril polymorph, multiple system atrophy patient-derived seeds |
|
0
|
76
|
8q8mA |
Tau - ad-phf long crossover |
|
0
|
75
|
8q9dA |
Tau - cte-mia15 (tau intermediate amyloid) |
|
1
|
76
|
8q8lA |
Tau - ad-lia7 (tau intermediate amyloid) |
|
0
|
76
|
8q8rA |
Tau - ad-phf |
|
0
|
75
|
8q9oA |
Cte tau intermediate amyloid (lia-17) |
|
1
|
113
|
8e7eA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient |
|
0
|
54
|
8ec7A |
Hnrnpa2 d290v lcd pm3 |
|
1
|
113
|
8e7dA |
Cryo-em structure of wild-type transthyretin amyloid from heart tissue |
|
1
|
112
|
8e7hA |
Cryo-em structure of cardiac amyloid fibril from a wild-type amyloidosis patient |
|
1
|
111
|
8e7jA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient |
|
0
|
112
|
8e7iA |
Cryo-em structure of cardiac amyloid fibril from a variant attr p24s amyloidosis patient |
|
1
|
71
|
8q8uA |
Tau - cte-mia1 (tau intermediate amyloid) |
|
0
|
75
|
8q8vA |
Tau - cte-mia3 |
|
0
|
74
|
8q7lA |
Tau - ad-mia6 (tau intermediate amyloid) |
|
0
|
75
|
8q9cA |
Tau - cte-mia14 (tau intermediate amyloid) |
|
1
|
75
|
8q7tA |
Tau - ad-mia11 |
|
0
|
72
|
8q2lA |
Tau - ad-mia4 |
|
0
|
69
|
8q9fA |
Tau - cte-lia3 (tau intermediate amyloid) |
|
0
|
73
|
8q9iA |
Tau - cte-lia6 (tau intermediate amyloid) |
|
0
|
74
|
8q8yA |
Tau - cte-mia6 (tau intermediate amyloid) |
|
0
|
75
|
8q9mA |
Tau - cte-type i (tau intermediate amyloid) |
|
0
|
73
|
8q9lA |
Tau - cte-lia14 (tau intermediate amyloid) |
|
0
|
73
|
8q9hA |
Tau - cte-lia4 (tau intermediate amyloid) |
|
0
|
73
|
8q9jA |
Tau - cte-lia7 (tau intermediate amyloid) |
|
0
|
75
|
8q98A |
Tau - cte-mia8 (tau intermediate amyloid) |
|
0
|
68
|
8q8cA |
Tau - ad-mia10 (intermediate amyloid) |
